USE OF THE WHOLE-EMBRYO CULTURE SYSTEM IN DRUG SAFETY ASSESSMENT

被引:18
作者
BECHTER, R
SCHON, H
机构
关键词
D O I
10.1016/0887-2333(88)90008-2
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
引用
收藏
页码:195 / 203
页数:9
相关论文
共 25 条
[1]   THE EFFECTS OF DIFFERENT CHEMICAL FORMS OF A TEST COMPOUND ON EMBRYOTOXICITY, DISTRIBUTION AND METABOLISM INVITRO [J].
BECHTER, R ;
BROUILLARD, JF .
TOXICOLOGY IN VITRO, 1988, 2 (03) :181-188
[2]  
BRIGGS GG, 1986, DRUGS PREGNANCY LACT
[3]   QUANTITATION OF RAT EMBRYONIC-DEVELOPMENT INVITRO - A MORPHOLOGICAL SCORING SYSTEM [J].
BROWN, NA ;
FABRO, S .
TERATOLOGY, 1981, 24 (01) :65-78
[4]  
DAHLQVIST R, 1984, EUR J RESPIR DIS, V65, P81
[5]  
Dennler H J, 1983, ZFA (Stuttgart), V59, P1646
[6]  
FRISHMAN WH, 1983, NEW ENGL J MED, V308, P940
[7]   BETA-ADRENERGIC-BLOCKADE - AN UPDATE [J].
FRISHMAN, WH ;
TEICHER, M .
CARDIOLOGY, 1985, 72 (5-6) :280-296
[8]   PHARMACOKINETICS OF TRIAMTERENE AFTER IV ADMINISTRATION TO MAN - DETERMINATION OF BIOAVAILABILITY [J].
GILFRICH, HJ ;
KREMER, G ;
MOHRKE, W ;
MUTSCHLER, E ;
VOLGER, KD .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (02) :237-241
[9]  
HARTMANN HG, 1985, SCHWEIZ MED WSCHR, V115, P939
[10]  
Heinonen O., 1977, BIRTH DEFECTS DRUGS, P286